|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.605 USD | -5.03% |
|
-4.70% | +2.54% |
| Market Cap | 20Cr 18Cr 17Cr 15Cr 29Cr 1.93TCr 30Cr 197.97Cr 77Cr 953.03Cr 77Cr 75Cr 3.32TCr | P/E 2026 * |
-3.45x | P/E 2027 * | -5.63x |
|---|---|---|---|---|---|
| Enterprise Value | 20Cr 18Cr 17Cr 15Cr 29Cr 1.93TCr 30Cr 197.97Cr 77Cr 953.03Cr 77Cr 75Cr 3.32TCr | EV / Sales 2026 * |
170x | EV / Sales 2027 * | 4.47x |
| Free-Float |
82.58% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Outlook Therapeutics, Inc.
| 1 day | -5.03% | ||
| 1 week | -4.70% | ||
| Current month | +121.93% | ||
| 1 month | +92.18% | ||
| 3 months | +706.02% | ||
| 6 months | -13.13% | ||
| Current year | +2.54% |
| 1 week | 1.53 |  | 1.79 |
| 1 month | 0.68 | | 1.88 |
| Current year | 0.16 | | 1.88 |
| 1 year | 0.16 | | 3.39 |
| 3 years | 0.16 | | 37 |
| 5 years | 0.16 | | 65.4 |
| 10 years | 0.16 | | 878.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jahr
CEO | Chief Executive Officer | 54 | 01/07/2025 |
Lawrence Kenyon
CEO | Chief Executive Officer | 60 | 03/12/2024 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Lawrence Kenyon
BRD | Director/Board Member | 60 | 02/08/2018 |
Kurt Hilzinger
BRD | Director/Board Member | 65 | 11/12/2015 |
| Chairman | 41 | 31/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/06 | Buy | Director | 29,000 | 0.0181% | ||
| 28/05 | Gms Ventures & Investments
| Buy | Company | 3,95,16,849 | 24.6751% | |
| 27/05 | Buy | Chairman | 1,22,174 | 0.1471% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.03% | -4.70% | +1.26% | -95.34% | 20Cr | |
| +1.15% | +5.94% | -3.40% | +2.32% | 4.66TCr | |
| -3.86% | +9.49% | +404.46% | +593.79% | 4.1TCr | |
| +0.09% | +12.92% | +22.73% | -13.95% | 3.23TCr | |
| -1.45% | +2.92% | +17.40% | +59.39% | 3.22TCr | |
| -3.29% | +2.85% | +13.80% | +30.30% | 2.55TCr | |
| +1.39% | +11.78% | - | - | 1.64TCr | |
| -0.66% | +12.87% | +70.27% | +122.51% | 1.53TCr | |
| +0.56% | +5.09% | +13.43% | +17.88% | 1.36TCr | |
| -1.60% | +4.68% | +101.34% | +93.88% | 1.33TCr | |
| Average | -1.26% | +8.53% | +71.26% | +90.09% | 2.36TCr | |
| Weighted average by Cap. | -0.97% | +10.35% | +93.89% | +136.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12L 10.5L 10L 9L 17.04L 11Cr 17.35L 1.16Cr 45.15L 5.6Cr 45.08L 44.08L 20Cr | 4.57Cr 4Cr 3.69Cr 3.45Cr 6.49Cr 432.36Cr 6.61Cr 44Cr 17Cr 213.35Cr 17Cr 17Cr 743.28Cr |
| Net income | -5.22Cr -4.57Cr -4.22Cr -3.93Cr -7.41Cr -493.37Cr -7.54Cr -51Cr -20Cr -243.46Cr -20Cr -19Cr -848.16Cr | -4.23Cr -3.71Cr -3.42Cr -3.19Cr -6.01Cr -400.24Cr -6.12Cr -41Cr -16Cr -197.51Cr -16Cr -16Cr -688.06Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/26/01 | $1.624 | -3.93% | 48,65,429 |
| 29/26/29 | $1.690 | -1.17% | 79,24,993 |
| 26/26/26 | $1.710 | +6.21% | 1,14,91,945 |
| 25/26/25 | $1.610 | -4.17% | 91,47,785 |
| 24/26/24 | $1.680 | -1.18% | 86,76,520 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OTLK Stock
Select your edition
All financial news and data tailored to specific country editions
